Ultragenyx CEO Buys 76,000 Shares and 133,000 Options – Insider Confidence Signals Upcoming Upside
CEO Emil Kakkis’s bulk purchase of Ultragenyx shares and options signals hidden upside and a bullish insider confidence, urging investors to watch upcoming clinical milestones.
- Ultragenyx Pharmaceutical Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read